Gregory Berk
Director/Board Member bij Inflection Biosciences Ltd.
Profiel
Gregory I.
Berk is currently a Director at Inflection Biosciences Ltd.
and Beyond Cancer, Ltd.
He is also a Member of the American Society of Clinical Oncology, Inc. and the American Society of Hematology.
Previously, he served as President, Director & Chief Medical Officer at Sideris Pharmaceuticals, Inc., Medical Director at Network for Medical Communication & Research LLC, Vice President-Global Clinical Development at Abraxis BioScience, Inc., Chief Medical Officer & Senior Vice President at Talon Therapeutics, Inc., and Faculty Member at Cornell University.
He was also Chief Medical Officer at GT Biopharma, Inc., DNIB Unwind, Inc., Intellikine LLC, and Verastem, Inc. Additionally, he served as a Chief Medical Officer at Celularity, Inc. Dr. Berk holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Tulane University (Louisiana).
Actieve functies van Gregory Berk
Bedrijven | Functie | Begin |
---|---|---|
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Inflection Biosciences Ltd.
Inflection Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Inflection Biosciences Ltd. is an Irish drug development company that focuses on discovering and developing small molecule therapeutics to address major unmet needs in cancer, autoimmune, and inflammatory diseases. Inflection Biosciences is based in Blackrock, IE. The private company's pipeline includes IBL-202, a first-in-class dual PIM kinase and PI3K inhibitor in development for B-cell malignancies, AML, and multiple myeloma, and the IBL-100 series, which comprises selective pan-PIM kinase inhibitors. The partnered pipeline includes AUM302, a PIM/PI3K/mTOR inhibitor being developed by AUM Biosciences. | Director/Board Member | 19-10-2020 |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Director/Board Member | 03-02-2022 |
Eerdere bekende functies van Gregory Berk
Bedrijven | Functie | Einde |
---|---|---|
GT BIOPHARMA, INC. | Chief Executive Officer | 02-03-2022 |
VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 19-01-2017 |
DNIB UNWIND INC | Chief Tech/Sci/R&D Officer | 14-01-2014 |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 01-05-2012 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Chief Tech/Sci/R&D Officer | 01-05-2009 |
Opleiding van Gregory Berk
Case Western Reserve University | Doctorate Degree |
Tulane University (Louisiana) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GT BIOPHARMA, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
CELULARITY INC. | Commercial Services |
Bedrijven in privébezit | 11 |
---|---|
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
Network for Medical Communication & Research LLC
Network for Medical Communication & Research LLC Other Consumer ServicesConsumer Services Network for Medical Communication and Research LLC provides medical educational programs to doctors. It offers education programs on gastrointestinal cancer, hematology, oncology, and lung cancer. The company was founded by Stanley H. Winokur and Joseph C. Allegra in 1997 and is headquartered in Atlanta, GA. | Consumer Services |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Inflection Biosciences Ltd.
Inflection Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Inflection Biosciences Ltd. is an Irish drug development company that focuses on discovering and developing small molecule therapeutics to address major unmet needs in cancer, autoimmune, and inflammatory diseases. Inflection Biosciences is based in Blackrock, IE. The private company's pipeline includes IBL-202, a first-in-class dual PIM kinase and PI3K inhibitor in development for B-cell malignancies, AML, and multiple myeloma, and the IBL-100 series, which comprises selective pan-PIM kinase inhibitors. The partnered pipeline includes AUM302, a PIM/PI3K/mTOR inhibitor being developed by AUM Biosciences. | Health Technology |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Health Technology |